FibroGen Inc (FGEN)
1.06
-0.08
(-7.02%)
USD |
NASDAQ |
Apr 23, 16:00
1.06
0.00 (0.00%)
After-Hours: 20:00
FibroGen Price: 1.06 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 1.15 | 1.26 | 1.05 | 1.06 | 1.282M |
| Apr 22, 2024 | 1.15 | 1.17 | 1.08 | 1.14 | 803876.0 |
| Apr 19, 2024 | 1.16 | 1.18 | 1.05 | 1.15 | 1.313M |
| Apr 18, 2024 | 1.26 | 1.29 | 1.14 | 1.17 | 1.278M |
| Apr 17, 2024 | 1.30 | 1.33 | 1.24 | 1.27 | 1.031M |
| Apr 16, 2024 | 1.28 | 1.35 | 1.25 | 1.30 | 863694.0 |
| Apr 15, 2024 | 1.30 | 1.37 | 1.24 | 1.31 | 1.265M |
| Apr 12, 2024 | 1.35 | 1.35 | 1.23 | 1.30 | 1.140M |
| Apr 11, 2024 | 1.45 | 1.465 | 1.35 | 1.36 | 1.162M |
| Apr 10, 2024 | 1.49 | 1.51 | 1.36 | 1.43 | 1.356M |
| Apr 09, 2024 | 1.62 | 1.63 | 1.485 | 1.51 | 1.014M |
| Apr 08, 2024 | 1.63 | 1.69 | 1.56 | 1.63 | 1.198M |
| Apr 05, 2024 | 1.56 | 1.695 | 1.51 | 1.62 | 1.620M |
| Apr 04, 2024 | 1.41 | 1.815 | 1.385 | 1.58 | 4.161M |
| Apr 03, 2024 | 2.14 | 2.15 | 1.180 | 1.47 | 10.34M |
| Apr 02, 2024 | 2.28 | 2.33 | 2.10 | 2.16 | 932124.0 |
| Apr 01, 2024 | 2.35 | 2.398 | 2.17 | 2.36 | 1.276M |
| Mar 28, 2024 | 2.58 | 2.59 | 2.31 | 2.35 | 1.357M |
| Mar 27, 2024 | 2.46 | 2.68 | 2.30 | 2.58 | 1.846M |
| Mar 26, 2024 | 2.67 | 2.79 | 2.410 | 2.44 | 1.540M |
| Mar 25, 2024 | 2.59 | 2.80 | 2.55 | 2.64 | 1.625M |
| Mar 22, 2024 | 2.43 | 2.66 | 2.37 | 2.58 | 1.565M |
| Mar 21, 2024 | 2.37 | 2.49 | 2.32 | 2.43 | 1.066M |
| Mar 20, 2024 | 2.34 | 2.39 | 2.155 | 2.36 | 1.523M |
| Mar 19, 2024 | 2.15 | 2.395 | 2.15 | 2.35 | 1.270M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.3801
Minimum
Nov 10 2023
55.72
Maximum
Feb 12 2021
23.25
Average
18.71
Median
Mar 27 2023
Price Benchmarks
| Emergent BioSolutions Inc | 2.29 |
| Annovis Bio Inc | 11.88 |
| Geron Corp | 3.50 |
| Regulus Therapeutics Inc | 2.26 |
| Fate Therapeutics Inc | 4.54 |
Price Related Metrics
| PS Ratio | 0.6980 |
| Earnings Yield | -276.4% |
| Market Cap | 104.70M |